This list reflects information regarding the application as of the approval date; it is not updated with regard to applicant or application status changes.
|Indication for Use||Applicant||Approval Date|
Anticoagulant Sodium Citrate 4% w/v Solution, USP
|Use only with automated apheresis devices in the collection of human plasma or in performing therapeutic plasma exchange procedures||Haemonetics Corp
400 Wood Road
Braintree, MA 02184